Introduction
Alzheimer’s disease continues to be one of the most challenging global health issues of our time. As populations age, the need for innovative research, effective treatments, and compassionate care grows stronger each year. To support this critical mission, the University of Sydney, in partnership with Sydney Health Partners and Equity Trustees via the Mason Foundation, is offering a Postgraduate Research Scholarship in Alzheimer’s Disease for 2026.
This fully funded PhD scholarship offers domestic students an opportunity to make a meaningful contribution to the future of healthcare and the lives of people living with Alzheimer’s. It not only provides financial support but also opens doors to a research ecosystem that bridges universities, hospitals, and leading medical research institutes in Australia.
Scholarship Overview
| Scholarship Name | Postgraduate Research Scholarship in Alzheimer’s Disease |
|---|---|
| Institution | The University of Sydney |
| Faculty | Faculty of Medicine and Health |
| Funding Source | The Mason Foundation via Equity Trustees Limited |
| Value | AUD $41,753 per annum |
| Duration | Up to 3.5 years |
| Level of Study | PhD (Doctor of Philosophy) |
| Location | Sydney, Australia |
| Eligibility | Domestic PhD students |
| Application Open Date | 10 November 2025 |
| Application Close Date | 15 December 2025 |
Purpose of the Scholarship
The Postgraduate Research Scholarship in Alzheimer’s Disease was established to empower talented researchers who are dedicated to enhancing health outcomes for Alzheimer’s patients. The scholarship supports clinical and health services research that aims to:
- Improve healthcare delivery systems
- Enhance the care experience for patients and their families
- Elevate the quality of life for people living with Alzheimer’s disease
This initiative aligns with the University of Sydney’s mission to lead transformative health research and deliver solutions that have real-world impact.
About the University of Sydney and Sydney Health Partners
The University of Sydney is one of Australia’s oldest and most prestigious institutions, renowned globally for its excellence in medicine, science, and public health research. It is home to leading experts in neuroscience, ageing, and healthcare innovation.
This scholarship is managed by Sydney Health Partners (SHP) a collaborative alliance between five major health services and ten affiliated medical research institutes. SHP aims to accelerate the translation of research evidence into clinical practice, ensuring that discoveries reach patients faster and more effectively.
Together, these organizations foster a powerful research environment where PhD students can work alongside world-class clinicians, scientists, and healthcare professionals.
Scholarship Benefits
The Postgraduate Research Scholarship in Alzheimer’s Disease provides comprehensive financial support to enable recipients to focus entirely on their research.
Key Benefits:
- Stipend Allowance:
AUD $41,753 per year (tax-free) for up to 3.5 years - Research Focus:
Funding supports projects directly related to improving healthcare delivery, care experiences, or quality of life for Alzheimer’s patients - Collaborative Research Environment:
Access to Sydney Health Partners’ extensive network of hospitals, universities, and medical research institutes - Professional Growth:
Scholars benefit from interdisciplinary supervision, skill-building workshops, and access to state-of-the-art research facilities
This scholarship is a prestigious and career-defining opportunity for students aspiring to specialize in Alzheimer’s research and clinical innovation.
Eligibility Criteria
To be eligible for this scholarship, applicants must meet the following requirements:
- Domestic Student Status:
The applicant must be an Australian citizen or permanent resident. - PhD Admission:
Must have an unconditional offer of admission, be currently enrolled, or be willing to apply for full-time PhD study within the Faculty of Medicine and Health at the University of Sydney. - Research Focus:
The proposed project must involve clinical or health services research in Alzheimer’s disease, contributing to better care delivery or patient outcomes. - Academic Excellence:
Applicants must demonstrate strong academic performance, research potential, and commitment to Alzheimer’s or neurological research.
Selection Criteria
Selection for this scholarship is competitive and merit-based. Candidates are assessed on:
- Academic Merit: Evidence of previous research excellence or publications
- Research Proposal: Quality, originality, and feasibility of the proposed PhD research
- Cover Letter: Personal motivation and alignment with Alzheimer’s research goals
- Curriculum Vitae (CV): Demonstrating relevant experience, education, and achievements
- Supervisor Support: A formal statement from a University of Sydney academic supervisor endorsing the project
Shortlisted applicants may also be invited to attend an interview as part of the selection process.
Application Timeline
| Milestone | Date |
|---|---|
| Applications Open | 10 November 2025 |
| Applications Close | 15 December 2025 |
| Scholarship Commencement | Research Period 1 or 2, 2026 |
Applicants are encouraged to start preparing early securing supervisor support and refining research proposals well in advance can significantly enhance application strength.
How to Apply
Interested candidates must submit an online application via the University of Sydney Scholarships Portal.
Application Components:
- Completed online application form
- Cover letter detailing research interests
- Research proposal outlining objectives and methodology
- Updated CV highlighting relevant academic and research experience
- Statement of support from a prospective supervisor
- Academic transcripts and proof of citizenship or residency
Apply here: University of Sydney Scholarship Portal
Terms and Conditions Highlights
The scholarship includes structured policies to ensure fairness and progress. Key provisions include:
- Duration: 3.5 years maximum, no extension allowed
- Progress Evaluation: Annual progress review required
- Leave Entitlements:
- 20 working days of recreation leave per year
- 10 working days of sick leave per year
- Overseas Research: Up to 12 months allowed with prior approval
- Suspension: Up to 12 months permitted under special circumstances
- Termination: May occur due to withdrawal, unsatisfactory progress, or receipt of another primary scholarship
Students are expected to acknowledge the support of the Mason Foundation and Sydney Health Partners in all research publications and presentations.
Why This Scholarship Matters
1. Driving Innovation in Alzheimer’s Care
This scholarship nurtures researchers who can translate lab-based discoveries into improved clinical care, leading to better patient outcomes and family support systems.
2. Building Leadership in Health Research
Recipients gain exposure to multi-institutional collaborations, equipping them to lead interdisciplinary teams in healthcare reform and medical innovation.
3. Improving Quality of Life
By supporting research into patient-centered care and healthcare delivery, this scholarship helps build solutions that improve dignity, comfort, and wellbeing for those affected by Alzheimer’s.
4. Empowering Australia’s Next Generation of Scientists
It reflects Australia’s commitment to global health challenges and ensures that talented scholars are financially supported to make lasting contributions to medical science.
About Alzheimer’s Disease and the Urgent Need for Research
Alzheimer’s disease affects millions worldwide, with rising prevalence across Australia. As the leading cause of dementia, it impacts not only patients but also caregivers, families, and the healthcare system at large.
Research in this field is vital for:
- Understanding disease mechanisms
- Developing effective therapies
- Designing innovative models of care
This PhD scholarship is an essential step toward addressing these challenges through science, compassion, and evidence-based practice.
About the Mason Foundation
The Mason Foundation, managed by Equity Trustees, plays a crucial role in funding medical research across Australia. Its mission is to advance knowledge and improve quality of life for those affected by Alzheimer’s disease and related conditions. By supporting initiatives like this postgraduate scholarship, the Mason Foundation ensures that promising researchers have the resources needed to make impactful discoveries.
Why Choose the University of Sydney for PhD Studies
- World-Class Reputation: Ranked among the top universities globally for medical and health sciences
- Collaborative Ecosystem: Partnerships with leading hospitals and research institutes
- Exceptional Supervision: Access to internationally recognized experts in neuroscience and clinical care
- Vibrant Research Culture: Supportive environment encouraging innovation and interdisciplinary collaboration
Choosing the University of Sydney means joining a legacy of academic excellence and societal impact.
Summary of Key Facts
| Aspect | Details |
|---|---|
| Scholarship | Postgraduate Research Scholarship in Alzheimer’s Disease |
| Value | $41,753 per annum |
| Duration | Up to 3.5 years |
| Eligibility | Domestic PhD students |
| Application Deadline | 15 December 2025 |
| Research Focus | Clinical/health services research in Alzheimer’s disease |
| Funded by | Mason Foundation via Equity Trustees |
| Managed by | Sydney Health Partners, University of Sydney |
Final Thoughts
The Postgraduate Research Scholarship in Alzheimer’s Disease at the University of Sydney represents more than just financial support it is a gateway to meaningful scientific contribution. For aspiring researchers passionate about transforming Alzheimer’s care and improving patient outcomes, this scholarship offers a rare chance to combine academic excellence with real-world impact.
Apply early, prepare thoroughly, and take this opportunity to be part of Australia’s mission to fight Alzheimer’s disease through research, compassion, and innovation.
About The Author
